Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1992-02-06
1996-12-10
Kim, Kay K. A.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
435 693, 4353201, 530395, 530403, 530868, 4241841, 4241851, 4241931, 514 8, C12N 506, C12N 510, C07K 1474
Patent
active
055830315
ABSTRACT:
The invention features an isolated sample of mammalian class II major histocompatibility heterodimers which are membrane-associated or in soluble form, and which are capable of binding added antigenic peptide; methods for producing large amounts of the soluble or membrane-associated histocompatibility protein by expression of DNA encoding the .alpha. and .beta. polypeptides; and methods for loading these heterodimers with any desired antigen.
REFERENCES:
patent: 4478823 (1984-10-01), Sanderson
patent: 4816397 (1989-03-01), Boss et al.
patent: 5130297 (1992-07-01), Sharma et al.
patent: 5260442 (1993-11-01), Clark et al.
patent: 5314813 (1994-05-01), Peterson et al.
Marguiles, D. H. et al. Immunol Res. 6;101-116(1987). "Engineering Soluble, Major Histocompatibility molecules: why and how."
Robinson, M. A. et al in Fundamental Immunology (W F Paul, ed.)(1989), "MHC Antigens and Genes". pp. 488-539.
Stern, L. J., et al, Cell 68:465-477 (Feb. 1992) "The human class II MHC protein HLA-DRI assembles as empty a B heterodimers in the absence of antigenic peptide".
Paul, W. F. (ed), Fundamental Immunology (1989), pp. 70-72.
Germain, R. N., et al. Nature 353:134-139 (12 Sep. 1991), "MHC Class II structure, occupancy and surface expression determined by post-endoplasmic antigen binding".
Jackson, M. R., et al., P.N.A.S. (USA) 89:12117-12121 (Dec., 1992), "Empty and peptide-containing conformers of class I major histocompatitiblity complex molecules expressed in Drosophila melanogaster cells".
Luckow, V. A., et al., Virology 170:31-39 (1989), "High level epxression of nofused foreign genes with Autographa californica nuclear polyhedrosis virus expression vectors".
Peterson, M., et al., Nature 345:172-174 (10 May 1990), "Invariant chain influences the immunological recognition of MHC class II molecules".
Stern, L., et al., Cell 68:465-477 (Feb. 7, 1992), "The human class II MHC protein HLA-DR1 assembles as empty alpha-beta heterodimers in the absence fo antigenic peptide".
Traunecker, A., et al., Nature 331:84-86 (7 Jan. 1988), "Soluble CD4 molecules neutralize human immunodeficiency virus type 1".
Rose et al., Cell, vol. 30, Oct. 1982, pp. 753-762.
Luckow et al., Bio/Technology, vol. 6, issued Jan. 1988, pp. 47-55.
Long et al., Human Immunology, vol. 31(4), Issued Aug. 1991, pp. 229-235.
Wiman et al., Proc. Natl. Acad. Sci, USA, vol. 79, pp. 1703-1707, Mar. 1982.
Wake et al., Proc. Natl. Acad. Sci, USA, vol. 79, pp. 6979-6983, Nov. 1982.
Kvist et al., Cell, vol. 29, pp. 61-69, May 1982.
Sharma et al., Proc. Natl. Acad. Sci. USA, 88:11465-11469, 1991.
Rudensky et al., Nature 353:622-627, 1991.
Davidson et al., Cell 67:105-116, 1991.
Germain et al. Nature 353:134-139, 1991.
Tampe et al., Proc. Natl. Acad. Sci. USA, 88:4661-4665, 1991.
Falk et al., Nature 351:290-296, 1991.
Ortiz-Navarrete et al., Proc. Natl. Acad. Sci. USA 88:3594-3597, 1991.
Wettstein et al., J. Exp. Med. 174:219-228, 1991.
De Bruijn et al., Eur. J. Immunol. 21:2963-2970, 1991.
Gorga et al., Res. Immunol. 142:401-407, 1991.
Rothbard et al., Annu. Rev. Immunol. 9:527-565, 1991.
Jardetzky et al., Nature 353:326-329, 1991.
Van Bleek et al., Nature 348:213-216, 1990.
O'Sullivan et al., J. Immunol. 145:1799-1808, 1990.
Ljunggren et al., Nature 346:476-480, 1990.
Townsend et al., Cell 62:285-295, 1990.
Yewdell et al., Cell 62:203-206, 1990.
Harding et al., Proc. Natl. Acad. Sci. USA 87:5553-5557, 1990.
Neefjes et al., Cell 61:171-183, 1990.
Roche et al., The Journal of Immunology 144:1849-1856, 1990.
Guagliardi et al., Nature 343:133-139, 1990.
Jardetzky et al., EMBOJ. 9:1797-1803, 1990.
Busch et al., Journal of Immunological Methods, 134:1-22, 1990.
Townsend et al., Nature 340:443-448, 1989.
Ceppellini et al., Nature 339:392-394, 1989.
Nuchtern et al., Nature 339:223-226, 1989.
Luckow et al., Virology 170:31-39, 1989.
Chen et al., Nature 337:743-745, 1989.
Traunecker et al., Immunology Today 10:29-32, 1989.
Buus et al., Science 242:1045-1047, 1988.
Bjorkman et al., Nature 329:506-512, 1987.
Quill et al., The Journal of Immunology 138:3704-3712, 1987.
Buus et al., Immunological Reviews 115-141, 1987.
Gorga et al., The Journal of Biological Chemistry 262:16087-16094, 1987.
Matsudaira, The Journal of Biological Chemistry 262:10035-10038, 1987.
Watts et al., Proc. Natl. Acad. Sci. USA 83:9660-9664, 1986.
Gorga et al., Cellular Immunology 103:160-173, 1986.
Buus et al., Cell 47:1071-1077, 1986.
Blake et al., Analytical Biochemistry 136:175-179, 1984.
Shackelford et al., The Journal of Immunology 130:274-282, 1983.
Lampson et al., The Journal of Immunology 125:293-299, 1980.
Laemmli, Nature 227:680-685, 1970.
Cunningham Thomas
Kim Kay K. A.
President and Fellows of Harvard College
LandOfFree
Empty major histocompatibility class II heterodimers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Empty major histocompatibility class II heterodimers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Empty major histocompatibility class II heterodimers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-423592